LMRNX
Price
$34.93
Change
+$0.24 (+0.69%)
Updated
Jun 18 closing price
Net Assets
908.82M
VBAIX
Price
$54.53
Change
+$0.43 (+0.79%)
Updated
Jun 18 closing price
Net Assets
64.1B
Interact to see
Advertisement

LMRNX vs VBAIX

LMRNX vs VBAIX Comparison Chart in %
View a ticker or compare two or three
VS
LMRNX vs. VBAIX commentary
Jun 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMRNX is a Buy and VBAIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VBAIX has more cash in the bank: 64.1B vs. LMRNX (909M). VBAIX pays higher dividends than LMRNX: VBAIX (2.00) vs LMRNX (0.95). LMRNX was incepted earlier than VBAIX: LMRNX (18 years) vs VBAIX (26 years). LMRNX (0.69) is less costly to investors than VBAIX (0.04). VBAIX is a more actively managed with annual turnover of: 31.00 vs. LMRNX (11.00). LMRNX has a lower initial minimum investment than VBAIX: LMRNX (1000000) vs VBAIX (5000000). VBAIX annual gain was more profitable for investors over the last year : 13.41 vs. LMRNX (10.38). LMRNX return over 5 years is better than : 38.26 vs. VBAIX (23.62).
LMRNXVBAIXLMRNX / VBAIX
Total Expense Ratio0.690.041,725%
Annual Report Gross Expense Ratio0.690.041,725%
Fund Existence18 years26 years-
Gain YTD2.4635.68143%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets909M64.1B1%
Annual Yield % from dividends0.952.0048%
Returns for 1 year10.3813.4177%
Returns for 3 years38.4927.82138%
Returns for 5 years38.2623.62162%
Returns for 10 years119.66102.21117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABEMX22.460.61
+2.79%
abrdn Emerging Markets Instl
NUESX23.180.19
+0.83%
Northern US Quality ESG K
MGRDX48.700.11
+0.23%
MFS International Growth R6
FSRNX17.48N/A
N/A
Fidelity Real Estate Index
ARFFX18.86-0.05
-0.26%
Ariel Focus Investor